JMP Securities reiterated its Market Outperform rating on Protagonist Therapeutics (NASDAQ:PTGX) with a steady price target ...

JMP Securities updated its outlook on Affirm Holdings Inc. (NASDAQ: NASDAQ:AFRM), increasing the price target to $85 from the ...

JMP Securities analyst Patrick Walravens maintained a Buy rating on Sprinklr (CXM – Research Report) today and set a price target of $17.00.

In a report released today, David Turkaly from JMP Securities maintained a Buy rating on Haemonetics (HAE – Research Report), with a price ...

Roku Inc. (NASDAQ:ROKU) posted excellent fiscal third-quarter 2024 results, exceeding $1 billion in total net sales for the ...